Compounding pharmacies make customized medicines for individual patients, and under section 503A of the Food, Drug, and Cosmetic Act, a pharmacy can compound from a bulk substance only if that substance has an official quality monograph, is a component of an FDA-approved drug, or has been formally added to an approved bulks list. BPC-157 qualifies on none of those counts, which is why the FDA placed it in Category 2 of its 503A bulk-substance review in September of 2023
With B-12 levels replenished, daily energy returns naturally
Can I get Restylane if I have a big event coming up
For inquiries, please call your desired office
The peptide is not FDA-approved for any medical condition and is typically used as a research compound or through compounding pharmacies
Join our Polaris Insiders program to get rewarded for loyalty with exclusive deals, news about upcoming products, and more